Nextleaf Provides Strategic Update: Canada's First 200-Pack Cannabis Softgels, and Opening of Distribution Facility
Nextleaf Solutions (OTCQB: OILFF) announced two significant developments: the launch of Canada's first 200-pack cannabis softgels under its Glacial Gold brand and the opening of a new distribution facility. The company is introducing 4 SKUs by end of 2025, including RSO Full-Spectrum 5:5, CBD 50, CBN:CBD 10:10, and CBG:THC 5:5 formats.
The company has begun operations at its new 2,500 square foot Nextleaf Distribution facility in Coquitlam, B.C., located near its licensed processing site. A Micro-Processing License Application has been submitted to Health Canada for this facility. Additionally, the company disclosed a lawsuit filed by former CEO Paul Pedersen regarding wrongful termination, which Nextleaf intends to defend.
Nextleaf Solutions (OTCQB: OILFF) ha annunciato due sviluppi importanti: il lancio delle prime softgel da 200 unità per il mercato canadese con il marchio Glacial Gold e l'apertura di un nuovo centro di distribuzione. L'azienda prevede di introdurre 4 SKU entro la fine del 2025, ovvero RSO Full-Spectrum 5:5, CBD 50, CBN:CBD 10:10 e CBG:THC 5:5.
Nextleaf ha avviato le operazioni nel nuovo magazzino di distribuzione di 2.500 piedi quadrati a Coquitlam (B.C.), vicino al suo sito di lavorazione autorizzato. Per questa struttura è stata presentata a Health Canada una domanda per una Micro-Processing License. Inoltre, la società ha reso nota una causa intentata dall'ex CEO Paul Pedersen per presunto licenziamento ingiustificato, causa che Nextleaf intende contestare in sede giudiziaria.
Nextleaf Solutions (OTCQB: OILFF) anunció dos novedades relevantes: el lanzamiento de las primeras cápsulas blandas de 200 unidades en Canadá bajo la marca Glacial Gold y la apertura de una nueva instalación de distribución. La compañía planea introducir 4 SKUs para finales de 2025, que incluyen RSO Full-Spectrum 5:5, CBD 50, CBN:CBD 10:10 y CBG:THC 5:5.
La empresa inició operaciones en su nueva instalación de distribución de 2.500 pies cuadrados en Coquitlam, B.C., situada cerca de su planta autorizada de procesamiento. Para esta instalación se ha presentado a Health Canada una solicitud de Micro-Processing License. Además, la compañía comunicó una demanda presentada por el ex CEO Paul Pedersen por despido injustificado, la cual Nextleaf tiene intención de defender.
Nextleaf Solutions (OTCQB: OILFF)는 두 가지 중요한 소식을 발표했습니다. 자사 브랜드 Glacial Gold로 캐나다 최초의 200팩 캐나비스 소프트젤을 출시하고 새로운 유통 시설을 개설한 것입니다. 회사는 2025년 말까지 4개 SKU를 도입할 예정이며, 품목은 RSO Full-Spectrum 5:5, CBD 50, CBN:CBD 10:10, CBG:THC 5:5입니다.
회사는 라이선스가 있는 가공 시설 인근에 위치한 코퀴틀람(브리티시컬럼비아)에 신설된 2,500 제곱피트 규모의 Nextleaf Distribution 시설에서 운영을 시작했습니다. 이 시설에 대해 Health Canada에 마이크로 가공(Micro-Processing) 라이선스 신청을 제출했습니다. 또한 전 CEO Paul Pedersen가 부당 해고를 주장하며 제기한 소송이 공개되었으며, Nextleaf는 이에 대해 방어할 계획입니다.
Nextleaf Solutions (OTCQB: OILFF) a annoncé deux évolutions majeures : le lancement des premières softgels de 200 unités au Canada sous la marque Glacial Gold et l'ouverture d'une nouvelle plateforme de distribution. La société prévoit d'introduire 4 SKUs d'ici fin 2025, comprenant RSO Full-Spectrum 5:5, CBD 50, CBN:CBD 10:10 et CBG:THC 5:5.
Nextleaf a commencé les opérations dans sa nouvelle installation de distribution de 2 500 pieds carrés à Coquitlam (C.-B.), située à proximité de son site de transformation agréé. Une demande de Micro-Processing License a été soumise à Santé Canada pour cette installation. Par ailleurs, la société a révélé un procès intenté par l'ancien PDG Paul Pedersen pour licenciement abusif, que Nextleaf entend contester.
Nextleaf Solutions (OTCQB: OILFF) meldet zwei bedeutende Entwicklungen: die Einführung der ersten 200er Cannabis-Softgels in Kanada unter der Marke Glacial Gold und die Eröffnung einer neuen Vertriebsstätte. Das Unternehmen plant, 4 SKUs bis Ende 2025 einzuführen: RSO Full-Spectrum 5:5, CBD 50, CBN:CBD 10:10 und CBG:THC 5:5.
Nextleaf hat den Betrieb seiner neuen 2.500 Quadratfuß großen Nextleaf Distribution-Anlage in Coquitlam, B.C. aufgenommen, die in der Nähe des lizenzierten Verarbeitungsstandorts liegt. Für diese Einrichtung wurde bei Health Canada ein Antrag auf eine Micro-Processing License gestellt. Zudem machte das Unternehmen eine Klage des ehemaligen CEO Paul Pedersen wegen angeblicher ungerechtfertigter Kündigung bekannt, gegen die Nextleaf sich verteidigen will.
- Launch of innovative first-to-market 200-pack cannabis softgels in Canada
- Glacial Gold is the top-selling softgel brand in Western Canada
- Ranks among top 4 softgel brands in Ontario
- Opening of new 2,500 sq ft distribution facility enhancing operational capabilities
- Legal challenge from former CEO Paul Pedersen claiming wrongful termination
Vancouver, British Columbia--(Newsfile Corp. - September 11, 2025) - Nextleaf Solutions Ltd. (CSE: OILS) (OTCQB: OILFF) (FSE: L0MA) ("Nextleaf", "OILS", or the "Company"), an innovation-driven life science company and licensed cannabis processor announces the launch of Canada's first 200-pack cannabis softgels under its house brand Glacial Gold™, and the opening of a new distribution facility. Together, these developments strengthen Nextleaf's position in existing markets and enhance its ability to pursue expansion into global medical channels.
Canada's First 200-Pack Softgels
Nextleaf Solutions, operating through its globally recognized innovative processing facility Nextleaf Labs, proudly announces the launch of Canada's first-ever 200-pack softgels under its house brand Glacial GoldTM.
Canada's First 200-pack cannabis softgels, from Glacial Gold by Nextleaf Labs
To view an enhanced version of this graphic, please visit:
https://images.newsfilecorp.com/files/5347/266025_bc7ffa43f4d49a31_001full.jpg
Available in RSO Full-Spectrum 5:5, alongside high potency CBD 50, CBN:CBD 10:10, and CBG:THC 5:5 formats to start. With 4 SKU's launching by the end of 2025, and more planned for 2026, the most up-to-date product availability and national listings can be found at www.glacial.gold.
The introduction of the 200-pack format represents a first for Canadian cannabis retail, and expands Glacial Gold's existing category leadership within non-combustible, ingestible extract formats.
Glacial Gold is the top selling brand in Western Canada for softgels and consistently ranks among the top 4 brands in Ontario. "Our new 200-pack format supports consumer demand for value and consistency, allowing consumers to establish and maintain wellness routines with fewer reorders and a more convenient, sustainable format," said Emma Andrews, CEO of Nextleaf.
"Cannabis softgels are becoming a trusted option for value-seeking, health-conscious consumers," Andrews continued. "By focusing on clean ingredients, consistent dosing, and transparency in manufacturing, Glacial Gold is well-positioned to be the trusted choice for non-combustible, everyday cannabis essentials."
Nextleaf Distribution
The Company has commenced operations from its 2,500 square foot facility, Nextleaf Distribution, located less than one kilometre from its licensed processing site in Coquitlam, B.C.
Nextleaf has also submitted a Micro-Processing License Application to Health Canada for this facility. They will focus on expanded activities to support their consumer-packaged goods portfolio from this second site.
Operations at the inaugural site, Nextleaf Labs, will remain focused on their globally recognized and multi-patented extraction process, distillation, formulation and manufacturing for their house branded vapes, oils and softgels, as well as bulk ingredient supply for Commercial Partners.
Nextleaf Discloses Lawsuit and Intention to Defend
The Company has been made aware that former Nextleaf CEO Paul Pedersen, has filed a lawsuit against the Company with the BC Supreme Court, citing wrongful termination. The Company firmly disagrees with and denies the allegations being made by Pedersen. The Company plans to vigorously defend itself against this lawsuit.
About Nextleaf Solutions Ltd.
Nextleaf® is an innovation-driven life science company, and licensed cannabis processor with a portfolio of federally regulated emerging consumer brands, market validated cannabis derivative products, and high-potency bulk ingredients. Nextleaf's multi-patented, highly automated, closed loop extraction and distillation technology sets the global standard for processing cannabis at scale.
With coast-to-coast distribution, Nextleaf branded products are sold through both medical and adult-use channels, featuring Glacial Gold™, which leads multiple categories nationally including softgels, vapes, and oils.
The Company has been issued 19 U.S. patents, and 75+ patents globally, on cannabinoid processing including extraction, distillation, and acetylation.
On behalf of the Board of Directors of the Company,
Emma Andrews, CEO
Contact: investors@nextleafsolutions.com
Follow Nextleaf Solutions on LinkedIn
Learn More: www.nextleafsolutions.com
Nextleaf trades as OILS on the Canadian Securities Exchange, OILFF on the OTCQB Market in the United States, and L0MA on the Frankfurt Stock Exchange.
Disclaimers and Disclosure Statements:
Certain statements contained in this press release constitute "forward-looking statements" within the meaning of applicable securities laws. All statements other than statements of historical fact contained in this press release, including, without limitation, statements regarding the Company's anticipated delivery of its products to provincial markets across Canada and those regarding the Company's strategy, plans, objectives, goals and targets, and any statements preceded by, followed by or that include the words "believe", "expect", "aim", "intend", "plan", "continue", "will", "may", "would", "anticipate", "estimate", "forecast", "predict", "project", "seek", "should" or similar expressions or the negative thereof, are forward-looking statements. These statements are not historical facts but instead represent only the Company's expectations, estimates and projections regarding future events. These statements are not guarantees of future performance and involve assumptions, risks and uncertainties that are difficult to predict. Therefore, actual results may differ materially from what is expressed, implied or forecasted in such forward-looking statements. Additional factors that could cause actual results, performance or achievements to differ materially include, but are not limited to the risk factors discussed in the Company's MD&A for the most recent fiscal period. Management provides forward-looking statements because it believes they provide useful information to investors when considering their investment objectives and cautions investors not to place undue reliance on forward-looking information. Consequently, all of the forward-looking statements made in this press release are qualified by these cautionary statements and other cautionary statements or factors contained herein, and there can be no assurance that the actual results or developments will be realized or, even if substantially realized, that they will have the expected consequences to, or effects on, the Company. These forward-looking statements are made as of the date of this press release and the Company assumes no obligation to update or revise them to reflect subsequent information, events or circumstances or otherwise, except as required by law. The Canadian Securities Exchange has not reviewed or approved the contents of this press release.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/266025
FAQ
What new products did Nextleaf (OILFF) announce in September 2025?
What is Nextleaf's (OILFF) market position in the cannabis softgel category?
What are the details of Nextleaf's new distribution facility?
What legal challenges is Nextleaf (OILFF) currently facing?
